Top Markets
Coin of the day
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Rank in Stocks #12775
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Share Price
$5.87
Last synced: 2022-11-08
Market Cap
$550.43M
Change (1 day)
1.03%
Change (1 year)
0.00%
Country
US
Trade Silverback Therapeutics, Inc. (SBTX)

Category

Price of SBTX with the market cap of B
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
SBTX
$5.87
Market Capitalization of Silverback Therapeutics, Inc.(SBTX)
Market Cap: $550.43M
As of August 2026 Silverback Therapeutics, Inc. has a market cap of $550.43M. This makes Silverback Therapeutics, Inc. the world's 12775th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Silverback Therapeutics, Inc. from 2020 to 2026
SBTX compared with Top 5 Most Popular stocks
Price of SBTX Asset B Mkt. of B Results
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$56,135.85 $550.43M
$5.264T +956,217.67%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$50,136.16 $550.43M
$4.701T +854,008.32%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$44,546.98 $550.43M
$4.177T +758,792.33%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$40,710.19 $550.43M
$3.817T +693,429.61%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$30,567.68 $550.43M
$2.866T +520,644.20%